Merdad Parsey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Merdad Parsey
Merdad Parsey is recorded as Board Member at ArriVent BioPharma, Inc. (AVBP). ArriVent BioPharma, Inc. reported in an 8-K filed April 28, 2025 that Merdad Parsey was appointed member of the Compensation Committee of the Board, effective April 28, 2025. ArriVent BioPharma, Inc. reported in an 8-K filed April 28, 2025 that Merdad Parsey was appointed director, effective April 28, 2025.
“Dr. Parsey was also appointed as a member of the Compensation Committee of the Board (the “Compensation Committee”).”
“On April 23, 2025 (the “Effective Time”), the Board approved, effective April 28, 2025, an increase in the size of the Board from seven (7) directors to eight (8) directors and appointed Merdad Parsey, M.D., Ph.D. to fill the newly created vacancy on the Board and to serve as a Class III director on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
ArriVent BioPharma, Inc. (AVBP)
SEC 8-K
Current2025-04-28–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ArriVent BioPharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Winston Kung CFO
- Robin LaChapelle COO
- James Kastenmayer General Counsel
- Chris W. Nolet Board Member
- James Healy Board Member
- John Hohneker Board Member
- John Hohneker, M.D. Board Member
- Kristine Peterson Board Member
- Merdad Parsey, M.D., Ph.D. Board Member
- Stuart Lutzker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.